Suchergebnisse - "2019-nCoV"

PubPharm (112)

1

Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines

enthalten in: Journal of medical virology | 2022

von Zhang, G. | Meng, W. | Chen, L. | +9

2

Longevity of immunity following COVID-19 vaccination : a comprehensive review of the currently approved vaccines

enthalten in: Human vaccines & immunotherapeutics | 2022

von Jamshidi, E. | Asgary, A. | Shafiekhani, P. | +5

3

Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Brunner, W. | Freilich, D. | Victory, J. | +11

4

Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain

enthalten in: Scientific reports | 2022

von Fernández-Ciriza, L. | González, �. | Del Pozo, J. | +5

5

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies

enthalten in: Transplant immunology | 2022

von Wijtvliet, V. | Verheyden, S. | Depreter, B. | +12

6

Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan : a prospective observational study

enthalten in: Expert review of vaccines | 2022

von Naito, T. | Tsuchida, N. | Kusunoki, S. | +4

7

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

enthalten in: Vaccine | 2022

von Kanokudom, S. | Assawakosri, S. | Suntronwong, N. | +17

8

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Nooka, A. | Shanmugasundaram, U. | Cheedarla, N. | +18

9

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2022

von Chiang, T. | Alejo, J. | Mitchell, J. | +14

10

Assessment of humoral immune response to two mRNA SARS-CoV-2 vaccines (Moderna and Pfizer) in healthcare workers fully vaccinated with and without a history of previous infection

enthalten in: Journal of applied microbiology | 2022

von Serrano, L. | Algarate, S. | Herrero-Cortina, B. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]